Alkermes Inc. and its California partner Amylin Pharmaceuticals Inc. have finally won approval from the FDA for the diabetes drug Bydureon after...

Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced a global Phase 3b study, ASCEND, that is being conducted to...

Seattle Genetics (Nasdaq: SGEN ) fell quite a bit after the company announced a change to the warnings section of the label for its blood cancer...

6,534,409 shares of Elan Corp. (ELN) traded hands on Monday, a 62.29% increase in volume compared to its 20-day average. The stock last traded at...

Elan (NYSE: ELN) was upgraded by equities research analysts at Deutsche Bank (NYSE: DB) from a "hold" rating to a "buy" rating in a research note...

These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Thursday morning.. . Affymetrix...

Elan (NYSE: ELN)'s stock had its "buy" rating reaffirmed by equities research analysts at Jefferies in a research note issued to investors on...

Diversification is all well and good, but there's nothing wrong with a well-run company that does a few things very well. With an enviable...

Posted on 10/20/11 at 8:56am by Allie Wickman . Today Biogen Idec (NASDAQ: BIIB ) and Elan Corporation, plc (NYSE: ELN ) announced that the U.S...

Johnson Johnson (NYSE: JNJ)'s stock had its "equal weight" rating reaffirmed by equities research analysts at Morgan Stanley (NYSE: MS) in a...